Search
for
Sort by
Research 871–900 of 1000+
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Association of androgenetic alopecia with metabolic syndrome: A case–control study on 100 patients in a tertiary care hospital in South India
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Alunni stranieri in Italia
- A Needs Assessment Survey for a Resource Center for African Immigrants and Refugees in St. Paul, Minnesota
- Fecal Microbiota and Metabolites Predict Metabolic Health Features Across Various Dietary Patterns
- METABOLIC, REPRODUCTIVE OUTCOMES AND SIDE EFFECTS AFTER THE ADMINISTRATION OF 100 MG DEHYDROEPIANDROSTERONE (DHEA) IN WOMEN WITH AN ADEQUATE OVARIAN RESERVE
- Role of alkaline ceramidase 1 (Acer1) in regulating epidermal homeostasis and tumorigenesis
- Administration of finasteride modulates depressive-like behavior in the forced swim task of male rats
- Frans van Gaal,Wat mij nou toch soms mankeert! Over de idealen, twijfels, en tweestrijd in het leven van Anton van den Ende (1910-2000), missionaris Nijmegen:Valkhof Pers ,2010 9789056252991
- Finasteride fra luci ed ombre
- A transgenic mouse model to study the role of epidermal growth factor (EGF) in hair and skin development
- Epidermal growth factor precursor retards hair growth cycle in vivo
- Our experience in the treatment of androgenic alopecia with minoxidil
- The effects of inositol in the female androgenetic alopecia: preliminary data
- Minoxidil is efficacious and safe when used for the treatment of androgenetic alopecia.
- Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
- Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation
- Androgenetic alopecia and risk of coronary artery disease
- The role of androgen therapy
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- Scientific Opinion on the substantiation of health claims related to soy isoflavones and protection of DNA, proteins and lipids from oxidative damage (ID 1286, 4245), maintenance of normal blood LDL cholesterol concentrations (ID 1135, 1704a, 3093a), reduction of vasomotor symptoms associated with menopause (ID 1654, 1704b, 2140, 3093b, 3154, 3590), maintenance of normal skin tonicity (ID 1704a), contribution to normal hair growth (ID 1704a, 4254), “cardiovascular health” (ID 3587), treatment …
- Metabolic syndrome — a new definition and management guidelines
- Skin disease related to metabolic syndrome in women
- Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- The association between serum ferritin and 25-hydroxyvitamin D and metabolic syndrome in Korean women: the Korea National Health and Nutrition Examination Survey 2010–2012
- Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship?
- Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling